A recent review of treatments for RLS and PLMD by the American Academy of Sleep Medicine has recommended that dopamine agonists should not be used as initial therapy for RLS due to the adverse effects of augmentation. This strengthens and supports the existing advice against the use of dopamine agonists except as a last resort.
Find out more about augmentation here https://www.rls-uk.org/augmentation-rebound
A WordPress Commenter
February 10, 2025 at 5:09 amHi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.